Investigational therapies for psoriasis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12894137.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As the pathogenesis of psoriasis is better understood, specific targeted therapies are being developed. In addition to alefacept, etanercept, efaluzimab, and infliximab, discussed in separate articles in this issue, numerous other investigational therapies are currently in clinical trials, some of which will likely be approved in the future. We review the most promising of these therapies and their mechanisms of action.
Medical subject headings
- Antibodies, Monoclonal
- Drugs, Investigational
- Immunoglobulin G
- Immunosuppressive Agents
- Psoriasis